Form 4 Tracker
Xeris Biopharma Holdings, Inc.
XERS

35 insider filings · Latest: Oct 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 1, 2026Oct 2 8:54 PMSteven PieperChief Financial Officer
Sale
5,000$9.41$47.0K1,351,053(D)

View →

Oct 1, 2026Oct 2 8:54 PMKevin MccullochPresident and Chief Operating Officer
Sale
15,000$9.41$141.1K1,599,208(D)

View →

Oct 1, 2026Oct 2 8:54 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,666$9.41$156.8K1,111,130(D)

View →

Oct 1, 2026Oct 1 8:26 PMBETH HECHT
Proposed Sale
16,666$9.56$159.3K—

View →

Sep 28, 2026Sep 29 8:59 PMKevin MccullochPresident and Chief Operating Officer
Sale
25,000$10.00$250.0K1,614,208(D)

View →

Sep 28, 2026Sep 28 8:19 PMKEVIN MCCULLOCH
Proposed Sale
70,000$9.10$637.0K—

View →

Sep 1, 2026Sep 1 10:21 PMKevin MccullochPresident and Chief Operating Officer
Sale
15,000$8.49$127.3K1,639,208(D)

View →

Sep 1, 2026Sep 1 10:21 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,666$8.49$141.4K1,127,796(D)

View →

Sep 1, 2026Sep 1 10:20 PMSteven PieperChief Financial Officer
Sale
5,000$8.50$42.5K1,356,053(D)

View →

Aug 12, 2026Aug 12 8:44 PMSteven PieperChief Financial Officer
Sale
5,000$8.50$42.5K1,361,053(D)

View →

Aug 12, 2026Aug 12 8:37 PMSTEVEN PIEPER
Proposed Sale
20,000$8.39$167.8K—

View →

Aug 3, 2026Aug 4 9:30 PMKevin MccullochPresident and Chief Operating Officer
Sale
15,000$8.02$120.2K1,676,126(D)

View →

Aug 3, 2026Aug 4 9:16 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,666$8.01$133.6K1,144,462(D)

View →

Jul 7, 2026Jul 7 9:11 PMSteven PieperChief Financial Officer
Sale
27,600$8.52$235.3K1,366,053(D)

View →

Jul 6, 2026Jul 7 9:11 PMSteven PieperChief Financial Officer
Sale
17,400$8.50$147.9K1,393,653(D)

View →

Jul 7, 2026Jul 7 8:37 PMSTEVEN PIEPER
Proposed Sale
27,600$8.37$231.0K—

View →

Jul 6, 2026Jul 6 8:39 PMSTEVEN PIEPER
Proposed Sale
17,400$8.28$144.1K—

View →

Jul 1, 2026Jul 2 8:40 PMKevin MccullochPresident and Chief Operating Officer
Sale
90,000$8.03$722.5K1,691,126(D)

View →

Jul 1, 2026Jul 2 8:38 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,666$8.03$133.9K1,161,128(D)

View →

Jul 1, 2026Jul 1 8:51 PMBETH HECHT
Proposed Sale
49,998$7.92$396.0K—

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 1, 2026Jul 2 10:01 PMNerissa KreherDirector
Grant/Award
37,910$8.0037,910(D)

View →

Jun 4, 2026Jun 5 10:39 PMGarheng KongDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:29 PMMarla PerskyDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:18 PMDawn HalkuffDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:18 PMBarbara-Jean Anne Bormann-KennedyDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:17 PMJohn JohnsonDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:16 PMJames Aloysius BradyDirector
Grant/Award
32,996$6.1532,996(D)

View →

Mar 12, 2026Mar 16 10:11 PMKevin MccullochPresident and Chief Operating Officer
Option Exercise
48,898$4.0979,996(D)

View →

Mar 5, 2026Mar 6 12:18 AMSteven PieperChief Financial Officer
Option Exercise
41,927$5.930(D)

View →

Jan 30, 2026Feb 2 11:13 PMJohn Patrick Shannon JrDirector, Chief Executive Officer and Director
Grant/Award
639,639$7.36639,639(D)

View →

Jan 30, 2026Feb 2 11:12 PMKevin MccullochPresident and Chief Operating Officer
Grant/Award
225,225$7.36225,225(D)

View →

Jan 30, 2026Feb 2 11:12 PMSteven PieperChief Financial Officer
Grant/Award
207,207$7.36207,207(D)

View →

Jan 30, 2026Feb 2 11:11 PMAnh Tu NguyenChief Medical Officer
Grant/Award
162,162$7.36162,162(D)

View →

Jan 30, 2026Feb 2 11:11 PMBeth HechtChief Legal Officer and Corporate Secretary
Grant/Award
162,162$7.36162,162(D)

View →